Literature DB >> 8811700

MRI in radiation-induced myelopathy and pharyngocutaneous fistula.

O Combarros1, F Iglesias, M V Guitera, J Berciano.   

Abstract

A patient developed a cervical myelopathy 20 months after radiotherapy for a carcinoma of the larynx. MRI showed an intramedullary lesion at C7. Although radiation myelopathy was suspected, tumour recurrence could not be excluded. A radiation-induced pharyngocutaneous fistula, confirmed histologically, appeared a month later. The fistula lay just anterior to the level of the spinal cord lesion, a finding useful in supporting a diagnosis of simultaneous radiation myelopathy.

Entities:  

Mesh:

Year:  1996        PMID: 8811700     DOI: 10.1007/bf02278140

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  6 in total

1.  Radiation myelopathy.

Authors:  C A PALLIS; S LOUIS; R L MORGAN
Journal:  Brain       Date:  1961-09       Impact factor: 13.501

2.  Pharyngo-cutaneous fistulae after laryngectomy. Influence of previous radiotherapy and prophylactic metronidazole.

Authors:  L V Johansen; J Overgaard; O Elbrønd
Journal:  Cancer       Date:  1988-02-15       Impact factor: 6.860

3.  MR imaging in radiation myelopathy.

Authors:  P Y Wang; W C Shen; J S Jan
Journal:  AJNR Am J Neuroradiol       Date:  1992 Jul-Aug       Impact factor: 3.825

Review 4.  Necrotizing myelopathy associated with malignancy. A clinicopathologic study of two cases and literature review.

Authors:  V J Ojeda
Journal:  Cancer       Date:  1984-03-01       Impact factor: 6.860

5.  Radiation-induced myelopathy and vertebral necrosis.

Authors:  D Martin; M Delacollette; J Collignon; G Dooms; J Lenelle; G Moonen; A Stevenaert
Journal:  Neuroradiology       Date:  1994-07       Impact factor: 2.804

6.  MRI in chronic progressive radiation myelopathy.

Authors:  P S Melki; P Halimi; P Wibault; P Masnou; D Doyon
Journal:  J Comput Assist Tomogr       Date:  1994 Jan-Feb       Impact factor: 1.826

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.